The global central
venous catheter market size was valued at US$ 1,167.4 million in 2017, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 - 2026).
[ClickPress, Mon Aug 05 2019] This report on the Global
Venous Stents Market analyzes the current and future scenario of the global market.
Central
venous access is frequently done in any critical care units with multiple indications and assessment of central
venous pressure (CVP) in critically ill patients is considered as keystone of management1,2.
The pathophysiological mechanism of CVI and VVs consists mainly in alteration of
venous return, triggered by the incompetence of
venous valves or by an intrinsic defect of the vein wall.
Medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX) reported on Thursday the receipt of the US Food and Drug Administration's premarket approval for the Venovo
venous stent for the treatment of iliofemoral
venous occlusive disease.
Portal
venous hemorrhage is uncommon and when traumatic, has mortality rates above 50% (1).
1, 2018 (HealthDay News) -- The risk of recurrence after incident
venous thromboembolism is high, particularly among patients with cancer-related
venous thromboembolism, according to a study published in the September issue of The American Journal of Medicine.
Boston Scientific has signed an agreement to acquire VENITI Inc., a privately-held company in Fremont, Calif., that has developed and commercialized the VICI
Venous Stent System for treating
venous obstructive disease.
Objective: To assess normal
venous anatomy of the cranium and its anatomical variants.
The vertebral
venous plexus (VVP) is also known as the epidural
venous plexus, longitudinal spinal veins, vertebral sinuses (Caballero et al., 2012) or Batson's plexus (Junquera et al., 2004).
[2]
Venous leg ulcers are the most serious type of chronic
venous incompetence.